ARD Podcast
BMJ Group
Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal committed to promoting the highest standards of scientific exchange and education. It covers all aspects of rheumatology, which includes the spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research. Concise scientific communication is encouraged and peer-reviewed proceedings of international meetings are featured. ARD is the official journal of EULAR.
Kategorien: Gesundheit
Hören Sie sich die letzte Folge an:
In this podcast, we discuss the evidence-based EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus (SLE) and systemic sclerosis (SSc).ARD's Social Media Advisor, Professor Laura Andreoli, speaks to Professor Carina Boström and Professor Ioannis Parodis, both from the Karolinska Institutet and the Karolinska University Hospital, Stockholm, Sweden, about their recent paper. Read it on the ARD website: https://ard.bmj.com/content/early/2023/08/23/ard-2023-224416 Please subscribe to the ARD podcast on all podcast platforms, including Apple Podcast, Google Podcasts, Stitcher and Spotify. If you enjoy the show, feel free to leave us a comment or a review on the podcast iTunes page -https://podcasts.apple.com/gb/podcast/ard-podcast/id1171058059 .
Vorherige Folgen
-
32 - A non-pharma approach in systemic lupus erythematosus and systemic sclerosisMon, 30 Oct 2023 - 0h
-
31 - Innate Lymphoid Cells link TGFb and fibrotic pathways in systemic sclerosis skinMon, 07 Feb 2022 - 0h
-
30 - EULAR recommendations for the management of systemic lupus erythematosusFri, 12 Jul 2019 - 0h
-
29 - Musculoskeletal diseases on the rise worldwide and affecting developed countries the mostMon, 03 Jun 2019 - 0h
-
28 - Three tips to get your manuscript published by ARDWed, 29 Aug 2018 - 0h
-
27 - Early inflammatory arthritis outcomes: what changed in the new millennium?Tue, 10 Jul 2018 - 0h
-
26 - Similar performance of Humira and BI695501 biosimilar in active rheumatoid arthritisWed, 28 Mar 2018 - 0h
-
25 - Patient and doctor discordance may reduce chances of remission in rheumatoid and psoriatic arthritisWed, 31 Jan 2018 - 0h
-
24 - Lupus and Hughes syndrome: EULAR recommendations for women’s health and family planningThu, 20 Apr 2017 - 0h
-
23 - Inflammatory arthritis and sicca syndrome induced by cancer treatmentTue, 06 Dec 2016 - 0h
-
22 - Johannes BijlsmaThu, 03 Jul 2014 - 0h
-
21 - Immunogenicity of anti-SARS-CoV-2 mRNA vaccines in patients with rheumatic diseasesThu, 29 Jul 2021 - 0h
-
20 - The EULAR COVID-19 database and its insights into risk factorsThu, 18 Mar 2021 - 0h
-
19 - Predictors of disease worsening in systemic sclerosisTue, 15 Sep 2020 - 0h
-
18 - Treating Cytokine Storm Syndrome in COVID-19 patients with glucocorticoids and tocilizumabThu, 06 Aug 2020 - 0h
-
17 - The dose dependent effect of statins on osteoporosisWed, 22 Apr 2020 - 0h
-
16 - A prediction score for individuals at risk to develop rheumatoid arthritisWed, 25 Mar 2020 - 0h
-
15 - Prediction of radiographic progression using synovitis characteristicsFri, 06 Mar 2020 - 0h
-
14 - Six-week treatment with low-dose prednisolone in patients with painful hand osteoarthritisTue, 18 Feb 2020 - 0h
-
13 - Highlights from ACR: guselkumab, ixekizumab and secukinumab in SpAThu, 23 Jan 2020 - 0h
-
12 - TULIP 2: Efficacy and Safety of Anifrolumab in PatientsMon, 23 Dec 2019 - 0h
-
11 - TULIP 1 - highlights from the ACR meetingTue, 10 Dec 2019 - 0h
-
10 - Capture Hi-C reveals novel drug targets in rheumatic diseasesThu, 22 Aug 2019 - 0h
